News

Home > news > Company news about Explorer X Advances Oculomics Research with Quantitative Multimodal Ocular Biomarker Analysis at ARVO 2026

Events

news

Cases

zhu00681@gmail.com

86-023-65456660

Contact Now

Explorer X Advances Oculomics Research with Quantitative Multimodal Ocular Biomarker Analysis at ARVO 2026

2026-04-28

High screen failure rates and qualitative only data in oculomics research can slow clinical breakthroughs and add complexity to longitudinal studies.

Explorer X is the world’s first integrated system for multimodal ocular biomarkers. It automates the quantitative analysis of more than 42 functional parameters, including retinal blood flow velocity and oxygen metabolism, helping researchers capture precise, objective, and reproducible data faster.

This year, SYSEYE ltd will be at the Association for Research in Vision and Ophthalmology ARVO 2026. Visit Booth 10050 to learn how Explorer X supports non invasive eye brain heart evaluation, AI powered insights, and advanced ophthalmic research.

Dr. Meihua LE, M.D., PhD., Chief Medical Officer at SYSEYE ltd, would be glad to connect with researchers, clinicians, and innovation partners interested in oculomics, medical innovation, and multimodal ocular biomarker research.

Send your inquiry directly to us

Tel：86-023-65456660

Email：zhu00681@gmail.com

About Us

Company Profile

Factory Tour

Quality Control

Sitemap

Events

news

Cases

Chongqing Bio Newvision Medical Equipment Ltd.

has been awarded 80 patents, and obtained ISO13485 quality system certification

We'll get back to you as soon as possible.